Improving Outcomes in HER2-Positive Breast Cancer: Analysis and Application of Evolving Data and Best Practices.
J Adv Pract Oncol
; 11(3): 271-274, 2020 Apr.
Article
in En
| MEDLINE
| ID: mdl-33598324
ABSTRACT
Through expert, case-based discussion, Jame Abraham, MD, and Kelley Mayden, MSN, FNP, AOCNP®, presented existing and emerging data for current and investigational therapies for HER2-positive breast cancer and their associated adverse events, in addition to best practices for managing central nervous system metastases.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
Language:
En
Journal:
J Adv Pract Oncol
Year:
2020
Document type:
Article